BUSCOPAN
20MG/ML INJ SOL 6X1ML
| SÚKL code | 0001430 |
|---|---|
| Name of the product | BUSCOPAN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | BUSCOPAN |
| Supplement | 20MG/ML INJ SOL 6X1ML |
| Strenght | 20MG/ML |
| Pharmaceutical form | Solution for injection |
| Package | 6X1ML |
| Route | Subcutaneous/intramucsular/intravenous use |
| Language of the pack | Czech |
| Wrap type | Ampoule |
| Legal status | na lékařský předpis |
| Active substance | HYOSCINE BUTYLBROMIDE (BUTYLSCOPOLAMINII BROMIDUM) |
| ATC group | A03BB01 |
| ATC group name | BUTYLSKOPOLAMINIUM |
Marketing authorisation information
| Registration Number | 73/ 009/71-S/C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2017 |
| MA Holder | Boehringer Ingelheim International GmbH, Ingelheim am Rhein |
| MA Holder country | NĚMECKO |
| Actual MA holder | Ipsen Consumer Healthcare, Boulogne- Billancourt |
| Actual MA holder country | FRANCIE |
cz